Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,374
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +12.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 151–200 of 1,023 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06039280	Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.	unknown	N/A	150	Institute of Liver and Biliary Sciences, IndiaOTHER	1	Sep 15, 2023	clinicaltrials
NCT05992584	Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC	unknown	Phase 2	30	Second Affiliated Hospital of Guangzhou Medical UniversityOTHER